yeztugo lenacapavir - Search News

News

FDA approval of new HIV prevention drug is a big deal

Revolutionary Drug That's “Closest Thing” To HIV Vaccine Gets FDA Approval

The Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that has been shown to act as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV. The drug,

MPR · 1h

Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

ConsumerAffairs · 7h

FDA approves twice-yearly injection for HIV prevention

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect Efficacy With 99.9% of Pa

24m

This twice-a-year shot to prevent HIV could stop transmission — if people can get it

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

Managed Healthcare Executive1d

Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

FDA approval of new HIV prevention drug is a big deal

Trending now